Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001104659-22-075786

President and CEO sold 4,000 shares at $12.00 ($48,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Doshi Dipal President and CEO 2022-06-27 Sale −4,000 $12.00 $48,000 210,710 D
Open-market sales · 4,000 sh · avg $12.00 · $48,000
Loading xslF345X03/tm2220048-1_4seq1.xml…